GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Other Stockholders Equity

Acticor Biotech (XPAR:ALACT) Other Stockholders Equity : €-0.01 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Other Stockholders Equity?

Acticor Biotech's Other Stockholders Equity for the quarter that ended in Jun. 2023 was €-0.01 Mil.

Acticor Biotech's quarterly Other Stockholders Equity declined from Jun. 2022 (€-0.00 Mil) to Dec. 2022 (€-0.01 Mil) and declined from Dec. 2022 (€-0.01 Mil) to Jun. 2023 (€-0.01 Mil).

Acticor Biotech's annual Other Stockholders Equity increased from Dec. 2020 (€-0.04 Mil) to Dec. 2021 (€-0.03 Mil) and increased from Dec. 2021 (€-0.03 Mil) to Dec. 2022 (€-0.01 Mil).


Acticor Biotech Other Stockholders Equity Historical Data

The historical data trend for Acticor Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Other Stockholders Equity Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial -7.90 -13.63 -0.04 -0.03 -0.01

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only -3.42 -0.03 - -0.01 -0.01

Acticor Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Acticor Biotech Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines